GlassScriptPhysician profile
Ashley D Reynolds
NPI 1538802038
$321.31
in general payments reported to CMS, 2019-2025
9 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $51.32 · 2024: $111 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $78.08 | 2025 | Wegovy |
| Kerecis Limited | $71.60 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $45.35 | 2024-2025 | Pico 7, Pico 14 |
| Integra Lifesciences Corporation | $32.74 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $20.17 | 2025 | Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $20.09 | 2023 | Echelon Flex |
| Eton Pharmaceuticals, INC. | $18.66 | 2025 | Alkindi, Increlex, Khindivi |
| Access Pro Medical, LLC | $17.58 | 2023 | Matriderm |
| Lifenet Health | $17.04 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.